SEC Form 4 · accession 0000885590-16-000086
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ari Kellen
Officer — EVP, Company Group Chairman
Period of report
Jan 26, 2016
Accepted (ET)
Jan 28, 2016 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1,F2,F3,F4 | Jan 26, 2016 | F | 3,317 | $88.98 | D | 535,450 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Matching Restricted Share Units.
- F2This number includes the maximum number of Common Shares that may be delivered in settlement of performance-based Restricted Share Units ("PSUs") that were previously reported on Form 4 in Table II. See notes (3) and (4).
- F3Includes unvested PSUs for up to 225,000 Common Shares that vest based on total shareholder return ("TSR") between a price of $107.96 starting on January 9, 2014 and the average stock price for the 20 trading days starting on each measurement dates: 25% on October 9, 2016, 50% January 9, 2017 and 25% on April 9, 2017 (or 25% on October 9, 2017, 50% on January 9, 2018 and 25% on April 9, 2018, if applicable). Unit vesting is contingent on TSR performance between 10% and 30% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels.
- F4Includes unvested PSUs for up to 225,000 Common Shares that vest based on TSR between a price of $54.15 starting on February 21, 2014 and the average stock price for the 20 trading days starting on each measurement dates: 25% on November 21, 2018, 50% February 21, 2019 and 25% on May 21, 2019 (or 25% on November 21, 2019, 50% on February 21, 2020 and 25% on May 21, 2020, if applicable). Unit vesting is contingent on TSR performance between 10% and 30% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels.